Enalapril vs Rituximab

## Enalapril vs Rituximab: Overview

This comparison examines the pharmacological differences between **Enalapril** and **Rituximab**.

## Mechanism of Action

**Enalapril**: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Enalapril — 11 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Enalapril — C20H28N2O5; Rituximab — N/A.

**Molecular Weight**: Enalapril — 376.4470 g/mol; Rituximab — N/A.

**Type**: Enalapril — Small molecule; Rituximab — Antibody.